Work

Secondary Acute Myeloid Leukemia (sAML) Treated with Amonafide (AS1413) + Cytarabine: Durable Responses in Poor-Risk AML

Year: 2008

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v112.11.2968.2968

Authors: Steven L Allen, Harry P Erba, David A. Rizzieri, Margaret O’Donnell, Bayard Powell, Ante S Lundberg, John M Bennett, Robert L Capizzi

Institutions: North Shore University Hospital, University of Michigan, Duke Medical Center, City Of Hope National Medical Center, Atrium Health Wake Forest Baptist, Wake Forest University, University of Rochester Medicine, University of Rochester

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2462549476

FWCI: 0.216

Cites:

Cited by: 1

Related to: 10